Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata is caused by an immune response, and targeting immune cells might help treat it.

Alopecia areata involves persistent gene abnormalities and immune activity, even in regrown hair, suggesting a risk of relapse.

Androgenetic alopecia involves immune cell disruptions, especially increased CD4+ T cells around hair follicles.

Protein profiling of forehead skin can help distinguish between frontal fibrosing alopecia and androgenetic alopecia.

Ingenol mebutate gel changes gene expression related to skin development and immune response in actinic keratosis.

Sun-exposed skin shows different cell activity and gene expression, suggesting targets to prevent skin aging and cancer.

CD2 might be a new treatment target for patchy alopecia areata.

Key genes like KRT27 and IGF-2 are crucial for hair follicle development in Qianhua Mutton Merino sheep.

TNF alpha in skin cells causes weight loss, hair and fat issues, and skin inflammation in mice.

Restoring immune privilege in hair follicles could help treat certain types of hair loss.

Injecting certain cells into mice caused hair loss, which was preventable with a specific inhibitor.

Alopecia areata is linked to immune system differences, with specific biomarkers like CXCL9 and CXCL10 being key for diagnosis and potential treatment targets.

The study found that immune responses disrupt hair growth cycles, causing hair loss in alopecia areata.

Targeting CD200 could be a new treatment for rheumatoid arthritis.

Alopecia areata involves immune response and gene changes affecting hair loss.

lncRNAs are important for understanding and treating skin diseases.

Acne is linked to inflammation and insulin resistance, and is associated with various syndromes that require different treatments.

Some treatments work better for different types of hair loss, and nutrients like iron and L-lysine are important for preventing hair loss.

Two main types of fibroblasts with unique functions and additional subtypes were identified in human skin.

Kids with alopecia areata may experience more stress but not necessarily feel more anxious or depressed than others.

Genetic differences affect COVID-19 severity and treatment development.

Double-stranded RNA causes inflammation in hair follicle cells, which may help understand and treat alopecia areata.

Blocking TSLP reduces skin inflammation and cell overgrowth in psoriasis.

Non-immune factors play a significant role in alopecia areata.

A man with rare skin changes on his fingers was diagnosed with multiple myeloma-linked amyloidosis.

People with alopecia areata have higher levels of RBP4 protein and antibodies against it.

Regulatory T cells enhance bone formation by influencing cell mechanics.

Melanocytes may trigger the immune response in alopecia areata, affecting hair regrowth.

Enhanced stem cells from the placenta can reduce fat cell formation in eye disease.

New treatments for hair growth and psoriasis may be possible, and gene differences could affect baldness and the severity of skin conditions.